ISSN: 2249-9504
CAS CODEN: IJPCDX

Abstracted and Indexed

open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing open access publisher, open access publishing, open access journals and articles, peer reviewed open access journals, insight medical publishing
+32 25889658
Google Scholar citation report
Citations : 3566

International Journal of Pharmaceutical, Chemical and Biological Sciences received 3566 citations as per google scholar report

International Journal of Pharmaceutical, Chemical and Biological Sciences peer review process verified at publons

SYNTHESIS AND CHARACTERIZATION OF SUBSTITUTED 1,3,4 THIADIAZOLE AS POTENTIAL ANTIMICROBIAL AGENTS

Abstract

Author(s): Manimaran T*, Anand Raj M, Jishala MI, Gopalasatheeskumar K, Parthiban S and Boopathi T

Background: Heterocyclic chemistry continues to draw the attention of synthetic organic chemists and is of great scientific interest. Objective: The present study was undertaken to assess the synthesis and characterization of substituted 1,3,4 thiadiazole as potential antimicrobial agents. Materials and Methods: synthesis of three (TDZ1, TDZ2, TDZ3) substituted hetero cyclic compounds and the study its Physio-chemical properties and structural interpretation by IR spectroscopy and NMR spectrum. And in vitro antifungal and antibacterial activities performed by nutrient agar medium. Results: All the compounds were screened for antibacterial activity. However the compounds TDZ 1 and TDZ 2 have shown promising antibacterial activity, while the remaining compound such as TDZ 3 have also shown moderate antibacterial activity, when compared with the standard drug Ciprofloxacin. Compounds TDZ 1 and TDZ 2 have shown promising antifungal activity, while the remaining compound such as TDZ 3 have also shown moderate antifungal activity, when compared with the standard drug Griseofulvin. Conclusion: In this work is concluded that there exists ample scope for the medicinal chemists to further study in this class of compounds and used for the treatment of various types of deadly microbial infections.

Get the App